Researchers at Indiana University School of Medicine are learning more about how special regulatory T cells can impact the immune system’s response and how those cells could be manipulated for potential treatments for food allergies and autoimmune diseases.
A large data analysis led by Indiana University School of Medicine Professor Benjamin Gaston, MD, shows a rare respiratory disease called primary ciliary dyskinesia (PCD) is more common than previously thought.
An Indiana University cancer researcher is leading an $11.4 million grant from the National Cancer Institute in which he and others across the country will work on identifying new treatments for tumors that develop in children, adolescents and adults with a common genetic condition.
A group of researchers led by Indiana University School of Medicine’s Benjamin Gaston, MD, has been awarded a research program project grant (P01) from the National Heart, Lung and Blood Institute. The award amounts to just over $12 million over the next five years and will fund the development of personalized therapeutic approaches for severe asthma.
Researchers with Indiana University School of Medicine Department of Obstetrics and Gynecology, Department of Pediatrics and Division of Clinical Pharmacology in the Department of Medicine are studying how certain drugs and medications affect pregnant and lactating women and their children thanks to a new, five-year, $17.1 million grant from the National Institutes of Health.
Indiana University School of Medicine researchers worked in collaboration with an international team of scientists to uncover why certain children get recurring urinary tract infections (UTIs) and others do not.
Indiana University School of Medicine has named Reuben Kapur, PhD, as the director of the Herman B Wells Center for Pediatric Research and the Department of Pediatrics vice chair for basic science research. Kapur has held the roles in an interim capacity since November 2019.
A group of researchers based at Indiana University School of Medicine and Riley Hospital for Children at IU Health has discovered that people who are clinically lacking androgen effects are three to four times more likely to have asthma than people in the general population.